Clinical Evaluation of Shilajatu in Madhumeha
DOI:
https://doi.org/10.47552/ijam.v6i1.515Keywords:
Diabetes, glycosylated hemoglobin, Shilajatu, Prameha, WHO-QOL-BREFAbstract
The incidence of diabetes mellitus is increasing rapidly because of changes in dietetic habits and life style. Continuous research is being done by scientists of various fields in order to achieve an effective cure of the disease. A great deal of work has also been done by Ayurvedic research scholars on various herbal and mineral drugs to find an effective treatment for Prameha. Shilajatu is one such drug which has been described for the management of Prameha in Ayurveda texts. The present study was conducted to clinically assess the efficacy of Shilajatu in the management of Prameha. Twenty two diabetic patients were selected for the study. The results were assessed in terms of symptomatic relief on the basis of scoring system, laboratory investigations including fasting blood glucose, post prandial blood glucose, glycosylated Hb, urine sugar, and a Questionnaire on Quality of Life. Statistically highly significant improvement (p <0.001) was observed on FBS and PPBS. Â Statistically significant improvement was observed on urine sugar and glycosylated haemoglobin with p <0.05 and p<0.01 respectively. In terms of subjective parameters also, highly significant improvement, with p <0.001 was observed in Shaithilya, Mukha Sosha, Sandhi Shoola, Prabhuta Mutrata, Pipasa and Kshudha. Highly significant improvement was observed in quality of life statistically with p <0.001. The study revealed that Shilajatu can be used as a drug in the management of Prameha.Downloads
Published
How to Cite
Issue
Section
License
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.
